Julie Papanek Grant, Director at Day One Biopharmaceuticals, Inc. (DAWN), sold 2,727,206 shares at $19.29 ($22.8M) on 2022-09-21, disclosed to the SEC on 2022-09-22.
Open-market sale of $22.8M DAWN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,500,000 | $0 | 0.0% |
| 2 | $18.54 | 607,497 | $11.3M | 49.5% |
| 3 | $18.54 | 607,497 | $11.3M | 49.5% |
| 4 | $19.29 | 6,106 | $118K | 0.5% |
| 5 | $19.29 | 6,106 | $118K | 0.5% |
| Total | $8.35 avg | 2,727,206 |
| $22.8M |
| 100% |
| Filing → |
| DAWN | SELL | 2023-01-04 | $1.0M | — | Filing → |
| DAWN | SELL | 2022-12-12 | $192K | — | Filing → |
| DAWN | SELL | 2022-12-05 | $320K | — | Filing → |